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Abstract
Background: Because 24-h esophageal pH monitoring is quite invasive, the diagnosis of
gastroesophageal reflux disease (GERD)-associated cough has usually been made based merely on
the clinical efficacy of treatment with proton pump inhibitor (PPI).
Case presentation: We recently encountered two patients with PPI-responsive chronic non-
productive cough for whom switching from bronchodilators and glucocorticosteroids to PPI
resulted in improvement of cough. The cough returned nearly to pre-administration level a few
weeks after discontinuation of PPI. Though GERD-associated cough was suspected, 24-h
esophageal pH monitoring revealed that the cough rarely involved gastric acid reflux. Following re-
initiation of PPI, the cough disappeared again.
Conclusion: PPI may improve cough unrelated to gastric acid reflux.
Background
Gastroesophageal reflux disease (GERD)-associated
cough is a well-known type of chronic, non-productive
cough [1]. Asthma, postnasal drip syndrome, and GERD
are the three most frequently identified causes of cough in
Western countries [1]. However, in Japan, GERD-associ-
ated cough has been found to account for only a few per-
cent of cases of chronic cough, while cough variant
asthma (CVA), atopic cough (AC), and sinobronchial syn-
drome (SBS) are major causes of chronic cough [2]. Pro-
ton pump inhibitors (PPIs) are considered the drugs of
choice for acid-related diseases including GERD [3].
In our institutions, chronic cough lasting more than 8
weeks without history of wheezing was assessed as
described in Figure 1.
We recently encountered two patients with PPI-responsive
chronic non-productive cough in whom 24-h esophageal
pH monitoring showed cough rarely associated with a
reflux episode. These cases show that PPI may improve
cough unrelated to an acid reflux episode.
Case 1
The patient was a 60-year-old man who had been suffer-
ing from isolated chronic non-productive cough for about
1 year. He discontinued smoking 9 months before the first
visit following development of this cough and had never
taken an ACE-I. Although he did not complain of heart-
burn and other symptoms suggestive of GERD, endo-
scopic assessment of the esophagus revealed reflux
esophagitis (Los Angeles classification Grade B). He had
had no respiratory infections during the 8-week period
preceding the first visit. No abnormal shadows were noted
on chest or paranasal sinus X-rays and chest CT scan. Cut-
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cough reflex hypersensitivity were set at below 10000 µg/
ml [4] and 3.9 µM [4]. Airway reversibility to inhaled β2
agonist was 6.5%, and testing for bronchial responsive-
ness to methacholine and cough reflex sensitivity revealed
no hyperresponsiveness (29053 µg/ml) and no hypersen-
sitivity (500 µM). Cell fractionation of bronchoalveolar
lavage fluid revealed percentages of macrophages, lym-
phocytes, neutrophils, and eosinophils of 91%, 7%,
1.7%, and 0.3%, respectively. Cough was evaluated based
on frequency and intensity as follows: 10 = cough level at
the first visit, 5 = half the level at the first visit, 0 = none.
Neither bronchodilator therapy nor anti-inflammatory
therapy improved the cough. PPI was given after discon-
tinuing bronchodilator and anti-inflammatory therapy.
The cough was markedly improved 2 weeks after initia-
tion of PPI (cough level 1), but returned nearly to pretreat-
ment level 3 weeks after discontinuation of PPI (cough
level 7, cough sensitivity 62.5 µM). On 24-h esophageal
pH monitoring performed prior to re-initiation of PPI to
determine the reason cough improved with PPI, the probe
was positioned in the lower esophagus 5 cm above the
upper border of the lower esophageal sphincter. Acid
reflux in the esophagus was considered present if pH was
4 or less [3]. Some cough and acid reflux were observed,
little cough-related acid reflux was noted (Figure 2, *;
cough, #; acid reflux, $; cough-related acid reflux). Follow-
ing re-initiation of PPI, the cough disappeared (cough
level 1, cough reflex sensitivity 62.5 µM).
Case 2
The patient was a 34-year-old man who had been suffer-
ing from isolated chronic non-productive cough since 31
years of age. He had stopped smoking at 32 years of age
and had never taken an ACE-I. Although he did not com-
plain of heartburn or other symptoms suggestive of
GERD, endoscopic assessment of the esophagus revealed
reflux esophagitis (Los Angeles classification Grade M).
He had had no respiratory infections within the 8-week
period preceding the first visit. No abnormal shadows
were noted on chest or paranasal sinus X-rays and chest
CT scan. Airway reversibility to inhaled β2 agonist was
13%, and testing of bronchial responsiveness to metha-
choline and cough reflex sensitivity revealed hyperrespon-
Assessment of chronic cough lasting more than 8 weeks without history of wheezingFigure 1
Assessment of chronic cough lasting more than 8 weeks without history of wheezing. After ruling out lung cancer, 
pulmonary tuberculosis, SBS, chronic bronchitis, and ACE-I-associated cough, bronchodilator therapy was initiated (oral clen-
buterol 40 µg/day for at least 2 weeks, and inhaled procaterol on demand). If this treatment was effective, CVA was diagnosed. 
If not, AC or GERD-associated cough was suspected, and glucocorticosteroid therapy was begun (oral prednisolone 30 mg/day 
for at least 1 week). If this treatment was effective, AC was diagnosed. If not, GERD-associated cough was suspected and PPI 
therapy was begun (oral lansoprazole 30 mg/day for at least 2 weeks).
After ruling out lung cancer, pulmonary tuberculosis, SBS,
chronic bronchitis, and ACE-I-associated cough
CVA or AC or GERD-associated cough were suspected
Bronchodilator therapy (oral clenbuterol 40 µg/day for at least 2 weeks, 
and inhaled procaterol on demand)
ineffective effective CVA
AC or GERD-associated cough were suspected
Glucocorticosteroid therapy (oral prednisolone 30 mg/day for at least 1 week)
ineffective effective AC
GERD-associated cough was suspected
PPI therapy (oral lansoprazole 30 mg/day for at least 2 weeks)Page 2 of 5
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µM). Cell fractionation of bronchoalveolar lavage fluid
revealed percentages of macrophages, lymphocytes, neu-
trophils, and eosinophils of 92%, 5%, 3%, and 0%,
respectively. Neither bronchodilator therapy nor anti-
inflammatory therapy improved the cough. PPI was given
after discontinuation of bronchodilator and anti-inflam-
matory therapy. The cough was markedly improved 1
week after initiation of PPI (cough level 1), but had
returned nearly to pre-administration level by 3 weeks
after discontinuation of PPI (cough level 8). On 24-h
esophageal pH monitoring performed prior to re-initia-
tion of PPI, some cough and acid reflux were observed,
but little cough-related acid reflux was noted (Figure 3, *;
cough, #; acid reflux, $; cough-related acid reflux). Follow-
ing re-initiation of PPI, the cough disappeared (cough
level 1, cough reflex sensitivity 31.2 µM).
Discussion and Conclusion
In case 2, although bronchial hyperresponsiveness to
methacholine was noted, the patient was not thought to
suffer from eosinophilic airway diseases such as bronchial
asthma or CVA, since no eosinophils were found in bron-
choalveolar lavage fluid, and neither bronchodilator ther-
apy nor high dosages of glucocorticosteroid therapy
improved the patient's cough. Although bronchial hyper-
responsiveness is one of the characteristics of bronchial
asthma, many clinically healthy volunteers exhibit high
degrees of bronchial responsiveness. We considered his
bronchial hyperresponsiveness unassociated with his
cough.
The endoscopic findings and good response to PPIs ini-
tially suggested that these patients suffered from GERD-
associated cough. However, 24-h esophageal pH monitor-
ing revealed that most of the coughing was not temporally
related to acid reflux episode. Although gastric acid is a
most important factor in it, the development of esopha-
geal damage depends on many factors including pepsin,
bile acids, and pancreatic enzymes [5]. Since PPIs relieved
their cough, if cough were the result of factors other than
gastric acid, PPIs presumably inhibited them. However,
this seems unlikely pharmacologically.
Because 24-h esophageal pH monitoring is quite invasive,
the diagnosis of GERD-associated cough has usually been
made based merely on the clinical efficacy of treatment
with PPI [6]. We also had diagnosed GERD-associated
Results of 24-h esophageal pH monitoring prior to re-initiation of PPI in case 1Fig re 2
Results of 24-h esophageal pH monitoring prior to re-initiation of PPI in case 1. Acid reflux in the esophagus was 
considered present if pH was 4 or lower. Some cough and acid reflux were observed, little cough-related acid reflux was noted 
(*; cough, #; acid reflux, $; cough-related acid reflux).
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ing these two patients. Fortunately, these two patients
gave us the opportunity to investigate their cough further.
The findings obtained suggested that PPI might be effec-
tive not only for cough temporally related to gastric acid
reflux but also for cough temporally unrelated to it.
Although it is possible that the efficacy of PPIs involves a
placebo effect, it was difficult to conclude this given their
clinical course, in which cough was markedly improved
after initiation of PPI, returned nearly to pretreatment
level after discontinuation of PPI, and improved again fol-
lowing re-initiation PPI.
Given the findings of esophagitis, we could consider their
suffering from GERD, but could not do GERD the etiology
of their cough since most of their coughing was not tem-
porally related to periods of acid reflux. Although it is
believed that cough in GERD patients can be relieved
regardless of whether it is temporally related to episodes
of reflux or not, cough and GERD are common conditions
and the likelihood of their co-existence by chance is high
[7], GERD-associated cough should thus be diagnosed
when the cough occurs simultaneously or within a few
minutes of acid reflux. Patients should not be diagnosed
as having GERD-associated cough just because they had
GERD and their cough improved after taking PPIs. We
suggest that the relationship between cough and reflux
episodes requires investigation. In our cases, we could not
consider cough GERD-associated since it occurred a few
hours or more after reflux episodes. If it had occurred
simultaneously or within a few minutes after reflux epi-
sodes, we would have diagnosed it as due to GERD. We
suggest that though they definitively had GERD, their
cough was not directly related to GERD.
Recent studies have indicated that PPIs have effects well
beyond acid suppression, and have revealed many types
of inflammatory cytokines in the esophageal mucosa of
GERD patients [8]. Hamaguchi et al. [9] showed that PPIs
can protect against esophageal inflammation via anti-
inflammatory effects including inhibition of cytokine pro-
duction, adhesion molecules expression, and neutrophil
activation. Oribe et al. [10] showed that PPI, but not his-
tamine H2 blocker, could directly decrease antigen-
induced cough reflex hypersensitivity. These findings sug-
gest that PPIs may act as new anti-tussive agents in treating
chronic cough.
While the mechanism of improvement of cough without
acid reflux remains unclear in detail, our most important
finding is that PPI-responsive cough is not simply identi-
cal to cough temporally related to gastric acid reflux. The
Results of 24-h esophageal pH monitoring prior to re-initiation of PPI in case 2Fig re 3
Results of 24-h esophageal pH monitoring prior to re-initiation of PPI in case 2. Acid reflux in the esophagus was 
considered present if pH was 4 or lower. Some cough and acid reflux were observed, little cough-related acid reflux was noted 
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type of PPI-responsive cough we are proposing includes
not only the same as our presenting cases, but also true
GERD-associated cough. Thus, 24-h esophageal pH mon-
itoring should be performed to determine the precise tem-
poral relationship between cough and acid reflux if
GERD-associated cough is to be diagnosed.
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